Other OTC - Delayed Quote • USD
Pivotal Therapeutics Inc. (PVTTF)
At close: March 23 at 4:17 PM EDT
Breakdown
TTM
Total Revenue
356.9940
Cost of Revenue
69.3180
Gross Profit
287.6760
Operating Expense
3,925.9920
Operating Income
-3,638.3160
Net Non Operating Interest Income Expense
-836.7650
Other Income Expense
839.9580
Pretax Income
-3,669.6410
Net Income Common Stockholders
-3,669.6410
Diluted NI Available to Com Stockholders
-3,669.6410
Basic EPS
-0.04
Diluted EPS
-0.04
Basic Average Shares
94,001.0490
Diluted Average Shares
94,001.0490
Total Operating Income as Reported
-3,890.1120
Rent Expense Supplemental
84.5170
Total Expenses
3,995.3100
Net Income from Continuing & Discontinued Operation
-3,669.6410
Normalized Income
-4,475.0810
Interest Expense
619.4870
Net Interest Income
-836.7650
EBIT
-3,050.1540
EBITDA
-2,311.8280
Reconciled Cost of Revenue
69.3180
Reconciled Depreciation
738.3260
Net Income from Continuing Operation Net Minority Interest
-3,669.6410
Total Unusual Items Excluding Goodwill
805.4400
Total Unusual Items
805.4400
Normalized EBITDA
-3,117.2680
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade